Global Amyotrophic Lateral Sclerosis Drugs Market Size, Status and Forecast 2019-2025

Amyotrophic lateral sclerosis is a neurodegenerative disease. ALS affects the nerve cells in the brain and spinal cord that control the voluntary muscles. It is also known as the Lou Gehrig’s disease. Amyotrophic lateral sclerosis can be caused due to various factors such as genetics or environmental factors such as exposure to toxic or infectious agents, viruses, physical trauma, diet, and behavioral and occupational factors.
Amyotrophic Lateral Sclerosis Drugs includes Riluzole, Edaravone (Radicava), CoQ10, Baclofen, Butylphthalide and Others. These drugs prolong amyotrophic lateral sclerosis (ALS) survival and slow the disease's progression in some people. Currently, only riluzole and edaravone have been approved for the treatment of ALS.
In 2018, the global Amyotrophic Lateral Sclerosis Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Amyotrophic Lateral Sclerosis Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Amyotrophic Lateral Sclerosis Drugs development in United States, Europe and China.

The key players covered in this study
Sanofi
Mitsubishi Tanabe Pharma
Mylan
Apotex
Glemark Generics
Sun Pharma
Covis Pharma
Lunan Pharma
CSPC Pharmaceutical
Ascend Laboratories
EISAI

Market segment by Type, the product can be split into
Riluzole
Edaravone (Radicava)
CoQ10
Butylphthalide
Others

Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Amyotrophic Lateral Sclerosis Drugs status, future forecast, growth opportunity, key market and key players.
To present the Amyotrophic Lateral Sclerosis Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Amyotrophic Lateral Sclerosis Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.